Expertise in
4
conditions

Anne Hanson-Borjesson

Stockholm, AB, SE 
Expertise in
4
conditions
Stockholm, AB, SE 

Overview

Anne Hanson-Borjesson practices practicing medicine in Stockholm, Sweden.

Ms. Hanson-Borjesson is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Dementia, Alzheimer's Disease, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, and Vascular Dementia.

She is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Stockholm, AB, Sweden
Other Locations
Goeteborg, O, Sweden
Moelndal, O, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug, Other
Study Drug: IONIS MAPTRx
Study Phase: Phase 1
A Phase Ib/IIa Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses, Regimens and Combinations of Tau Targeted Vaccines in Subjects With Early Alzheimer's Disease
A Phase Ib/IIa Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses, Regimens and Combinations of Tau Targeted Vaccines in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Other, Biological
Study Drugs: ACI-35.030 Anti-Tau Vaccine, JACI-35.054 Anti-Tau Vaccine
Study Phase: Phase 1/Phase 2
A 24 Months Randomised, Placebo-controlled, Parallel Group, Double Blinded, Multi Centre, Phase 2 Study to Assess Safety and Efficacy of AADvac1 Applied to Patients With Mild Alzheimer's Disease
A 24 Months Randomised, Placebo-controlled, Parallel Group, Double Blinded, Multi Centre, Phase 2 Study to Assess Safety and Efficacy of AADvac1 Applied to Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: November 14, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 2 Less Clinical Trials

45 Total Publications

New therapies and ongoing clinical trials in Alzheimer's disease
New therapies and ongoing clinical trials in Alzheimer's disease
Journal: Lakartidningen
Published: May 20, 2026

Frequently Asked Questions about Anne Hanson-Borjesson

Is Anne Hanson-Borjesson a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Anne Hanson-Borjesson is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anne Hanson-Borjesson participate in research or clinical trials?

Yes. Anne Hanson-Borjesson has published 45 articles and abstracts on conditions like Dementia. You can view a list of Anne Hanson-Borjesson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hanson-Borjesson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile